The global market for Outsourcing Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Outsourcing Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Outsourcing Drug Discovery.
The Outsourcing Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Outsourcing Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Outsourcing Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Albany Molecular Research, Inc.
Evotec AG
Asclepia MedChem Solutions
Aurelia Bioscience Ltd
Axxam SpA
BioDuro
Charles River Laboratories, Inc.
Charnwood Molecular
CreaGen Biosciences, Inc.
Crown Bioscience
Cyprotex PLC, an Evotec AG Company
Domainex
Nanosyn, Inc.
Olon Ricerca Biosciences
Pharmaron, Inc.
TCG Lifesciences Pvt Ltd.
Viva Biotech, Ltd.
WuXi AppTec Co. Ltd.
Segment by Type
Chemistry Services
Biology Services
High Throughput Screening Services
Lead Optimization Services
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Outsourcing Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Outsourcing Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemistry Services
1.2.3 Biology Services
1.2.4 High Throughput Screening Services
1.2.5 Lead Optimization Services
1.3 Market by Application
1.3.1 Global Outsourcing Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 OTC
1.3.3 Rx
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Outsourcing Drug Discovery Market Perspective (2020-2031)
2.2 Global Outsourcing Drug Discovery Growth Trends by Region
2.2.1 Global Outsourcing Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Outsourcing Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 Outsourcing Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 Outsourcing Drug Discovery Market Dynamics
2.3.1 Outsourcing Drug Discovery Industry Trends
2.3.2 Outsourcing Drug Discovery Market Drivers
2.3.3 Outsourcing Drug Discovery Market Challenges
2.3.4 Outsourcing Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Outsourcing Drug Discovery Players by Revenue
3.1.1 Global Top Outsourcing Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global Outsourcing Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global Outsourcing Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Outsourcing Drug Discovery Revenue
3.4 Global Outsourcing Drug Discovery Market Concentration Ratio
3.4.1 Global Outsourcing Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Outsourcing Drug Discovery Revenue in 2024
3.5 Global Key Players of Outsourcing Drug Discovery Head office and Area Served
3.6 Global Key Players of Outsourcing Drug Discovery, Product and Application
3.7 Global Key Players of Outsourcing Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Outsourcing Drug Discovery Breakdown Data by Type
4.1 Global Outsourcing Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global Outsourcing Drug Discovery Forecasted Market Size by Type (2026-2031)
5 Outsourcing Drug Discovery Breakdown Data by Application
5.1 Global Outsourcing Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global Outsourcing Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Outsourcing Drug Discovery Market Size (2020-2031)
6.2 North America Outsourcing Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Outsourcing Drug Discovery Market Size by Country (2020-2025)
6.4 North America Outsourcing Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Outsourcing Drug Discovery Market Size (2020-2031)
7.2 Europe Outsourcing Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Outsourcing Drug Discovery Market Size by Country (2020-2025)
7.4 Europe Outsourcing Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Outsourcing Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific Outsourcing Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Outsourcing Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific Outsourcing Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Outsourcing Drug Discovery Market Size (2020-2031)
9.2 Latin America Outsourcing Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Outsourcing Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America Outsourcing Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Outsourcing Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa Outsourcing Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Outsourcing Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa Outsourcing Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Albany Molecular Research, Inc.
11.1.1 Albany Molecular Research, Inc. Company Details
11.1.2 Albany Molecular Research, Inc. Business Overview
11.1.3 Albany Molecular Research, Inc. Outsourcing Drug Discovery Introduction
11.1.4 Albany Molecular Research, Inc. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.1.5 Albany Molecular Research, Inc. Recent Development
11.2 Evotec AG
11.2.1 Evotec AG Company Details
11.2.2 Evotec AG Business Overview
11.2.3 Evotec AG Outsourcing Drug Discovery Introduction
11.2.4 Evotec AG Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.2.5 Evotec AG Recent Development
11.3 Asclepia MedChem Solutions
11.3.1 Asclepia MedChem Solutions Company Details
11.3.2 Asclepia MedChem Solutions Business Overview
11.3.3 Asclepia MedChem Solutions Outsourcing Drug Discovery Introduction
11.3.4 Asclepia MedChem Solutions Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.3.5 Asclepia MedChem Solutions Recent Development
11.4 Aurelia Bioscience Ltd
11.4.1 Aurelia Bioscience Ltd Company Details
11.4.2 Aurelia Bioscience Ltd Business Overview
11.4.3 Aurelia Bioscience Ltd Outsourcing Drug Discovery Introduction
11.4.4 Aurelia Bioscience Ltd Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.4.5 Aurelia Bioscience Ltd Recent Development
11.5 Axxam SpA
11.5.1 Axxam SpA Company Details
11.5.2 Axxam SpA Business Overview
11.5.3 Axxam SpA Outsourcing Drug Discovery Introduction
11.5.4 Axxam SpA Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.5.5 Axxam SpA Recent Development
11.6 BioDuro
11.6.1 BioDuro Company Details
11.6.2 BioDuro Business Overview
11.6.3 BioDuro Outsourcing Drug Discovery Introduction
11.6.4 BioDuro Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.6.5 BioDuro Recent Development
11.7 Charles River Laboratories, Inc.
11.7.1 Charles River Laboratories, Inc. Company Details
11.7.2 Charles River Laboratories, Inc. Business Overview
11.7.3 Charles River Laboratories, Inc. Outsourcing Drug Discovery Introduction
11.7.4 Charles River Laboratories, Inc. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.7.5 Charles River Laboratories, Inc. Recent Development
11.8 Charnwood Molecular
11.8.1 Charnwood Molecular Company Details
11.8.2 Charnwood Molecular Business Overview
11.8.3 Charnwood Molecular Outsourcing Drug Discovery Introduction
11.8.4 Charnwood Molecular Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.8.5 Charnwood Molecular Recent Development
11.9 CreaGen Biosciences, Inc.
11.9.1 CreaGen Biosciences, Inc. Company Details
11.9.2 CreaGen Biosciences, Inc. Business Overview
11.9.3 CreaGen Biosciences, Inc. Outsourcing Drug Discovery Introduction
11.9.4 CreaGen Biosciences, Inc. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.9.5 CreaGen Biosciences, Inc. Recent Development
11.10 Crown Bioscience
11.10.1 Crown Bioscience Company Details
11.10.2 Crown Bioscience Business Overview
11.10.3 Crown Bioscience Outsourcing Drug Discovery Introduction
11.10.4 Crown Bioscience Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.10.5 Crown Bioscience Recent Development
11.11 Cyprotex PLC, an Evotec AG Company
11.11.1 Cyprotex PLC, an Evotec AG Company Company Details
11.11.2 Cyprotex PLC, an Evotec AG Company Business Overview
11.11.3 Cyprotex PLC, an Evotec AG Company Outsourcing Drug Discovery Introduction
11.11.4 Cyprotex PLC, an Evotec AG Company Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.11.5 Cyprotex PLC, an Evotec AG Company Recent Development
11.12 Domainex
11.12.1 Domainex Company Details
11.12.2 Domainex Business Overview
11.12.3 Domainex Outsourcing Drug Discovery Introduction
11.12.4 Domainex Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.12.5 Domainex Recent Development
11.13 Nanosyn, Inc.
11.13.1 Nanosyn, Inc. Company Details
11.13.2 Nanosyn, Inc. Business Overview
11.13.3 Nanosyn, Inc. Outsourcing Drug Discovery Introduction
11.13.4 Nanosyn, Inc. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.13.5 Nanosyn, Inc. Recent Development
11.14 Olon Ricerca Biosciences
11.14.1 Olon Ricerca Biosciences Company Details
11.14.2 Olon Ricerca Biosciences Business Overview
11.14.3 Olon Ricerca Biosciences Outsourcing Drug Discovery Introduction
11.14.4 Olon Ricerca Biosciences Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.14.5 Olon Ricerca Biosciences Recent Development
11.15 Pharmaron, Inc.
11.15.1 Pharmaron, Inc. Company Details
11.15.2 Pharmaron, Inc. Business Overview
11.15.3 Pharmaron, Inc. Outsourcing Drug Discovery Introduction
11.15.4 Pharmaron, Inc. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.15.5 Pharmaron, Inc. Recent Development
11.16 TCG Lifesciences Pvt Ltd.
11.16.1 TCG Lifesciences Pvt Ltd. Company Details
11.16.2 TCG Lifesciences Pvt Ltd. Business Overview
11.16.3 TCG Lifesciences Pvt Ltd. Outsourcing Drug Discovery Introduction
11.16.4 TCG Lifesciences Pvt Ltd. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.16.5 TCG Lifesciences Pvt Ltd. Recent Development
11.17 Viva Biotech, Ltd.
11.17.1 Viva Biotech, Ltd. Company Details
11.17.2 Viva Biotech, Ltd. Business Overview
11.17.3 Viva Biotech, Ltd. Outsourcing Drug Discovery Introduction
11.17.4 Viva Biotech, Ltd. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.17.5 Viva Biotech, Ltd. Recent Development
11.18 WuXi AppTec Co. Ltd.
11.18.1 WuXi AppTec Co. Ltd. Company Details
11.18.2 WuXi AppTec Co. Ltd. Business Overview
11.18.3 WuXi AppTec Co. Ltd. Outsourcing Drug Discovery Introduction
11.18.4 WuXi AppTec Co. Ltd. Revenue in Outsourcing Drug Discovery Business (2020-2025)
11.18.5 WuXi AppTec Co. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Albany Molecular Research, Inc.
Evotec AG
Asclepia MedChem Solutions
Aurelia Bioscience Ltd
Axxam SpA
BioDuro
Charles River Laboratories, Inc.
Charnwood Molecular
CreaGen Biosciences, Inc.
Crown Bioscience
Cyprotex PLC, an Evotec AG Company
Domainex
Nanosyn, Inc.
Olon Ricerca Biosciences
Pharmaron, Inc.
TCG Lifesciences Pvt Ltd.
Viva Biotech, Ltd.
WuXi AppTec Co. Ltd.
听
听
*If Applicable.
